Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition

BACKGROUND: Akt is a critical mediator of developmental skeletal muscle growth. Treatment with a soluble ActRIIB fusion protein (ActRIIB-mFc) increases skeletal muscle mass and strength by inhibiting myostatin and related peptides. Recent in vitro studies have suggested that Akt signaling is necessa...

Descripción completa

Detalles Bibliográficos
Autores principales: Goncalves, Marcus D., Pistilli, Emidio E., Balduzzi, Anthony, Birnbaum, Morris J., Lachey, Jennifer, Khurana, Tejvir S., Ahima, Rexford S.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939888/
https://www.ncbi.nlm.nih.gov/pubmed/20856813
http://dx.doi.org/10.1371/journal.pone.0012707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939888/
https://www.ncbi.nlm.nih.gov/pubmed/20856813
http://dx.doi.org/10.1371/journal.pone.0012707

Ejemplares similares